Esta web utiliza cookies técnicas, de personalización y de análisis, propias y de terceros, para anónimamente facilitarle la navegación y analizar estadísticas del uso de la web. Obtener más información
Resultados de búsqueda
-
Greenpeace and WWF, Teaching Note
Casadesus-Masanell, Ramon; Mitchell, JordanNota del Instructor HBS-708513-ETeaching Note for [708418] and [708417].Desde 0,00 €
-
eBay, Inc. and Amazon.com (A)
Casadesus-Masanell, Ramon; Thaker, AnantCaso HBS-712405-EDirección estratégicaThis case has been designed to explore strategic interactions among organizations with different business models. The case considers how a competitor successfully challenged the incumbent in a platform market defined by strong network effects and high switching costs. The case allows students to assess the advantages and disadvantages of eBay's platform business model in comparison to Amazon's retail business model; to evaluate business model per...Desde 8,20 €
-
KITEA (A): Democratizing Furniture in Morocco
Casadesus-Masanell, Ramon; Yucaoglu, GamzeCaso HBS-719420-EDirección estratégicaThe case opens in 2013 as Amine Benkirane, founder and CEO of the leading Moroccan furniture company KITEA, contemplates the loss his company has incurred for the first time in its 20-year history. The case then describes KITEA's origins and provides a detailed overview of the business plan that enabled Benkirane to bring affordable modern furniture in flatpacks to the Moroccan market, which had previously been dominated by unorganized artisans. ...Desde 8,20 €
-
Imprimis (A)
Casadesus-Masanell, Ramon; Elterman, Karen; Appel, MarcCaso HBS-717426-EIniciativa emprendedoraThis case examines the strategic choices and evolving business model of Imprimis Pharmaceuticals from the perspective of CEO Mark Baum. The A case provides a brief history of the company and of the compounding business, outlining the challenges faced by Imprimis in 2013. At the time, Imprimis was in the process of seeking FDA approval for a branded drug called Impracor. This process, already difficult, was further complicated by recent manufactur...Desde 8,20 €
-
Future of Big Pharma (Spanish version)
David W. Conklin; Murray J. Bryant; Danielle CadieuxCaso IVEY-9B05MS47Dirección estratégicaVarias novedades amenazaban al éxito de Pharma grande. Las patentes en las superproducciones bien conocidas alcanzaban vencimiento, y los fabricantes genéricos esperaban con impaciencia para producir copias a menor precio. En el mundo entero, los gobiernos tomaban un papel más activo en la determinación de los precios en los cuales las drogas podrían ser vendidas. La extensión de los programas del seguro del gobierno agregaba a la complejidad de ...Desde 8,20 €